A review of leukofiltration therapy for decreasing the morbidity associated with cardiopulmonary bypass and acute inflammatory bowel disease

Therapeutic Apheresis

Volumn 6, Issue 2, 2002, Pages 119-129

  Ortolano, Girolamo A ^a   Capetandes, Anthony ^a   Wenz, Barry ^a  

^a PALL CORPORATION   (United States)

Author keywords

Cardiopulmonary bypass; Cell adhesion molecules; Chemokines; Cytokines; Filtration; Inflammatory bowel disease; Leukocyte reduction; Reperfusion injury

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENZYME; OXIDIZING AGENT;

CARDIOPULMONARY BYPASS; ENDOTHELIUM CELL; ENTERITIS; GAS EXCHANGE; HEART MUSCLE INJURY; HEMOFILTRATION; HOSPITALIZATION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LONG TERM CARE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REMISSION; REPERFUSION INJURY; REVIEW;

ACUTE DISEASE; CARDIOPULMONARY BYPASS; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKAPHERESIS;

EID: 0036251968     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00338.x     Document Type: Review

References (73)

1. Adhesion molecules: Clinical implications
2. Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion
3. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass
4. Strategies for targeting complement inhibitors in ischemia/reperfusion injury
5. Role of plateletactivating factor in cardiovascular pathophysiology
6. The role of neutrophils in myocardial ischemia-reperfusion injury
7. Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage
8. The effects of pulsatile flow on the leukocyte depleting qualities of the Pall LG6 leukocyte depleting arterial line filter: A laboratory investigation
9. Laboratory investigation of the Pall LG 6 leukocyte depleting arterial line filter
10. Laboratory studies on the effect of Pall extracorporeal filters LG6 and AV6 on patients undergoing coronary bypass grafts
11. Modifying risk for extracorporeal circulation: Trial of four anti-inflammatory strategies
12. Clinical evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery
13. Leukodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements
14. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury
15. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report
16. Detrimental effects of cardiopulmonary bypass in cyanotic infants: Preventing the reoxygenation injury
17. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy
18. Leukocyte-depleted reperfusion of transplanted human hearts: A randomized, double-blind clinical trial
19. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study
20. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury
21. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery
22. Leukocyte depletion reduces postoperative oxygen requirements
23. Depletion of activated neutrophils by a filter during cardiac-valve surgery
24. Laboratory studies on the effect of Pall extracorporeal filters LG6 and AV6 on patients undergoing coronary bypass grafts
25. Leukocyte depletion during cardiac operation: A new approach through the venous bypass circuit
26. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass
27. Effects on complement, granulocytes and platelets of a leukocyte depletion filter during in vitro extracorporeal circulation
28. Leukocyte filtration during cardiopulmonary bypass hardly changed leukocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
29. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study
30. Depletion of neutrophils by filtration during aortocoronary bypass surgery transiently improves postoperative cardio-respiratory status
31. Clinical evaluation of the new Pall leukocyte-depleting blood cardioplegia filter (BC1)
32. Single leukocyte filter (Pall BC1B) fails in multi-dose cold blood cardioplegia
33. The effects of using a leukocyte removal filter during cold blood cardioplegia
34. Clinical evaluation of a leukocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery
35. Clinical evaluation of leukocytedepleted blood cardioplegia for pediatric open heart operation
36. Leukocytedepleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery
37. The effects of leukodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass
38. Etiology of the inflammatory bowel disease
39. Restitution at the cellular level: Regulation of the migrating phenotype
40. Autoimmunity in ulcerative colitis (UC): A predominant colonic mucosal B cell response against human tropomyosin isoform 5
41. Characterization of mucosal lymphoid aggregates in ulcerative colitis: Immune cell phenotype and TcR-gammadelta expression
42. Tissue injury in neutrophilic inflammation
43. Neutrophil migration across model intestinal epithelia: Monolayer disruption and subsequent events in epithelial repair
44. 99mTc-HMPAO planar white cell scanning
45. Review article: Quantitative leukocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy
46. 111-Indium autologous granulocytes in the detection of inflammatory bowel disease
47. Technetium leukocyte imaging in inflammatory bowel disease
48. Are 99mTc leukocyte scintigraphy and SBFT (small bowel follow through) studies useful in children suspected of having inflammatory bowel disease?
49. Technetium-99m-HMPAO-labeled leukocyte imaging in patients with seronegative spondyloarthropathies
50. Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings
51. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes
52. An index of inflammatory activity in patients with Crohn's disease
53. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease
54. Increased leukocyte adhesiveness and aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation
55. Serum tumor necrosis factor activity in inflammatory bowel disease
56. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis
57. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
58. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
59. Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease
60. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
61. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis
62. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease
63. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa
64. Adherence of human monocytes and NK cells to human TNF-alpha-stimulated porcine endothelial cells
65. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis
66. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease
67. Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease
68. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease
69. Complications of leukocytapheresis
70. A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis
71. Centrifugal leukocyte apheresis for ulcerative colitis
72. Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: Role of bystander suppression
73. Expression of leukocyte adhesion molecules by endothelial cells seeded on various polymer surfaces